Peng Chen

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Squamous Cell Carcinoma

Cross Sectional

Small Cell Lung Cancer

Top Venues

Thoracic cancer

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yuan Gao, Yingfang Feng, Shaochuan Liu, Yan Zhang, Jing Wang, Tingting Qin, Peng Chen, Kai Li
Immune-independent acquired resistance to PD-L1 antibody initiated by PD-L1 upregulation via PI3K/AKT signaling can be reversed by anlotinib. Cancer medicine (2023)
Ran Zuo, Fuyi Zhu, Cuicui Zhang, Jincheng Ma, Jinliang Chen, Ping Yue, Jinfang Cui, Yu Wang, Peng Chen
The response prediction and prognostic values of systemic inflammation response index in patients with advanced lung adenocarcinoma. Thoracic cancer (2023)
Dongqi Yuan, Fuyi Zhu, Ran Zuo, Yu Wang, Gengwei Huo, Jinfang Cui, Ping Yue, Peng Chen
High incidence and reversible bradycardia events following alectinib initiation. Thoracic cancer (2022)
Dongqi Yuan, Fuyi Zhu, Ran Zuo, Yu Wang, Gengwei Huo, Jinfang Cui, Ping Yue, Peng Chen
High incidence and reversible bradycardia events following alectinib initiation. Thoracic cancer 14 (5) (2022)
Dongqi Yuan, Fuyi Zhu, Ran Zuo, Yu Wang, Gengwei Huo, Jinfang Cui, Ping Yue, Peng Chen
High incidence and reversible bradycardia events following alectinib initiation. Thoracic cancer 14 (5) (2022)
Ran Zuo, Cuicui Zhang, Li Lin, Zhaoting Meng, Yajie Wang, Yudong Su, Mihray Abudurazik, Ye Du, Peng Chen
Durable efficacy of anlotinib in a patient with advanced thymic squamous cell carcinoma after multiline chemotherapy and apatinib: A case report and literature review. Thoracic cancer 11 (11) (2020)